J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 88 (2007), 481-486; DOI 10.1099/vir.0.82453-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Beer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Beer, M.
Agricola
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Beer, M.
© 2007 Society for General Microbiology

Short Communication

Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus

Thomas Bruun Rasmussen1, Åse Uttenthal1, Ilona Reimann2, Jens Nielsen1, Klaus Depner3 and Martin Beer3

1 Department of Virology, Danish Institute for Food and Veterinary Research, Lindholm, DK-4771 Kalvehave, Denmark
2 Institute of Molecular Biology, Friedrich-Loeffler-Institut, Boddenblick 5a, D-17493 Greifswald-Insel Riems, Germany
3 Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Boddenblick 5a, D-17493 Greifswald-Insel Riems, Germany

Correspondence
Thomas Bruun Rasmussen
thb{at}dfvf.dk

A chimeric pestivirus of border disease virus Gifhorn and bovine viral diarrhea virus CP7 (Meyers et al., 1996) was constructed. Virulence, immunogenicity and vaccine properties of the chimeric virus were studied in a vaccination–challenge experiment in pigs. The chimeric virus proved to be avirulent and neither chimeric virus nor viral RNA was detected in serum after vaccination. The safety of the vaccine was tested by horizontal transmission to sentinel pigs, which remained uninfected. The vaccine efficacy was examined by challenge infection with classical swine fever virus (CSFV) Eystrup. In ‘challenge controls’, the viral load of CSFV coincided with the development of pronounced clinical symptoms. In contrast, the vaccinated pigs showed transient and weak clinical signs. Analysis of the viral load in these pigs showed 1000-fold lower viral RNA levels compared to ‘challenge controls' and horizontal transmission of challenge virus to sentinel pigs was not observed.

A supplementary figure is available in JGV Online.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
F. Wehrle, S. Renzullo, A. Faust, M. Beer, V. Kaden, and M. A. Hofmann
Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines
J. Gen. Virol., August 1, 2007; 88(8): 2247 - 2258.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 by the Society for General Microbiology.